Get started
Author

Heiko Schuster

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
2014 · Matthew M. Gubin, Xiuli Zhang, et al. · Nature · 2,021
Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry
2015 · Etienne Caron, Daniel J. Kowalewski, et al. · Molecular & Cellular Proteomics · 224
The immunopeptidomic landscape of ovarian carcinomas
2017 · Heiko Schuster, Janet K. Peper, et al. · Proceedings of the National Academy of Sciences · 189
PDF
HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)
2014 · Daniel J. Kowalewski, Heiko Schuster, et al. · Proceedings of the National Academy of Sciences · 167
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
2019 · Markus W. Löffler, Christopher Mohr, et al. · Genome Medicine · 158
PDF
The SysteMHC Atlas project
2017 · Wenguang Shao, Patrick G A Pedrioli, et al. · Nucleic Acids Research · 133
PDF
Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy
2014 · C Berlin, D J Kowalewski, et al. · Leukemia · 130
An open-source computational and data resource to analyze digital maps of immunopeptidomes
2015 · Etienne Caron, Lucia Espona, et al. · eLife · 128
The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy
2015 · Simon Walz, Juliane S. Stickel, et al. · Blood · 115
Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices
2017 · Moreno Di Marco, Heiko Schuster, et al. · The Journal of Immunology · 106
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient
2016 · Markus W. Löffler, P. Anoop Chandran, et al. · Journal of Hepatology · 93
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial
2025 · Martin Wermke, Dejka M. Araujo, et al. · Nature Medicine · 89
Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer
2016 · Hans-Christian Bösmüller, Philipp Wagner, et al. · International Journal of Gynecological Cancer · 85
An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells
2014 · Janet Kerstin Peper, Heiko Schuster, et al. · Journal of Immunological Methods · 81
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
2022 · Markus W. Löffler, Stefania Gori, et al. · Clinical Cancer Research · 80
PDF
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
2018 · Tatjana Bilich, Annika Nelde, et al. · Blood · 74
PDF
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
2019 · Hans-Georg Rammensee, Karl-Heinz Wiesmüller, et al. · Journal for ImmunoTherapy of Cancer · 68
PDF
Dipeptides promote folding and peptide binding of MHC class I molecules
2013 · Sunil Kumar Saini, Katja Ostermeir, et al. · Proceedings of the National Academy of Sciences · 68
PDF
A tissue-based draft map of the murine MHC class I immunopeptidome
2018 · Heiko Schuster, Wenguang Shao, et al. · Scientific Data · 58
PDF
Dipeptides catalyze rapid peptide exchange on MHC class I molecules
2014 · Sunil Kumar Saini, Heiko Schuster, et al. · Proceedings of the National Academy of Sciences · 58
Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation
2018 · Markus W. Löffler, Daniel J. Kowalewski, et al. · Cancer Research · 56
Wound Fluid in Diabetic Foot Ulceration: More Than Just an Undefined Soup?
2013 · Markus W. Löffler, Heiko Schuster, et al. · The International Journal of Lower Extremity Wounds · 48
Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues
2022 · Peter Kubiniok, Ana Marcu, et al. · iScience · 45
MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies
2017 · J. Patrick Murphy, Prathyusha Konda, et al. · Journal of Proteome Research · 45
PDF
Quantitative immunopeptidomics reveals a tumor stroma–specific target for T cell therapy
2022 · Gloria B. Kim, Jens Fritsche, et al. · Science Translational Medicine · 41
PDF
Works count: 115
Citation count: 4,838
H-index: 32
I10-index: 40
Year
Topic
Type